-
1
-
-
27644548513
-
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial
-
Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21.
-
(2005)
Lancet
, vol.366
, pp. 1607-1621
-
-
Chen, Z.M.1
Jiang, L.X.2
Chen, Y.P.3
-
2
-
-
20244377701
-
Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology
-
Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
-
(2005)
Eur Heart J
, vol.26
, pp. 804-847
-
-
Silber, S.1
Albertsson, P.2
Aviles, F.F.3
-
3
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
DOI 10.1001/jama.288.19.2411
-
Steinhubl SR, Berger PB, Mann 3rd JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20. (Pubitemid 35340537)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.19
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Tift Mann III, J.3
Fry, E.T.A.4
DeLago, A.5
Wilmer, C.6
Topol, E.J.7
-
4
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
DOI 10.1056/NEJMoa010746
-
Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Pubitemid 32758501)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.7
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
Chrolavicius, S.4
Tognoni, G.5
Fox, K.K.6
-
5
-
-
0037117649
-
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
-
DOI 10.1161/01.CIR.0000015464.18023.0A
-
Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3. (Pubitemid 34408881)
-
(2002)
Circulation
, vol.105
, Issue.15
, pp. 1760-1763
-
-
Sabatine, M.S.1
Morrow, D.A.2
De Lemos, J.A.3
Gibson, C.M.4
Murphy, S.A.5
Rifai, N.6
McCabe, C.7
Antman, E.M.8
Cannon, C.P.9
Braunwald, E.10
-
6
-
-
33750924102
-
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
-
DOI 10.1093/eurheartj/ehl334
-
Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74. (Pubitemid 44729867)
-
(2006)
European Heart Journal
, vol.27
, Issue.22
, pp. 2667-2674
-
-
Biondi-Zoccai, G.G.L.1
Lotrionte, M.2
Agostoni, P.3
Abbate, A.4
Fusaro, M.5
Burzotta, F.6
Testa, L.7
Sheiban, I.8
Sangiorgi, G.9
-
7
-
-
6444220783
-
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes
-
DOI 10.1161/01.CIR.0000145171.89690.B4
-
Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-7. (Pubitemid 39407340)
-
(2004)
Circulation
, vol.110
, Issue.16
, pp. 2361-2367
-
-
Collet, J.P.1
Montalescot, G.2
Blanchet, B.3
Tanguy, M.L.4
Golmard, J.L.5
Choussat, R.6
Beygui, F.7
Payot, L.8
Vignolles, N.9
Metzger, J.P.10
Thomas, D.11
-
8
-
-
33846125284
-
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
-
[published online: Dec 5, 2006: doi:10.1001/jama.297.2.joc60179]
-
Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2006 [published online: Dec 5, 2006: doi:10.1001/jama.297.2.joc60179].
-
(2006)
JAMA
-
-
Eisenstein, E.L.1
Anstrom, K.J.2
Kong, D.F.3
-
9
-
-
0034070620
-
Catastrophic outcomes of noncardiac surgery soon after coronary stenting
-
DOI 10.1016/S0735-1097(00)00521-0, PII S0735109700005210
-
Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-94. (Pubitemid 30206904)
-
(2000)
Journal of the American College of Cardiology
, vol.35
, Issue.5
, pp. 1288-1294
-
-
Kaluza, G.L.1
Joseph, J.2
Lee, J.R.3
Raizner, M.E.4
Raizner, A.E.5
-
10
-
-
33845319222
-
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting versus bare-metal stents
-
DOI 10.1016/j.jacc.2006.10.026, PII S073510970602523X
-
Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91. (Pubitemid 44881238)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.12
, pp. 2584-2591
-
-
Pfisterer, M.1
Brunner-La Rocca, H.P.2
Buser, P.T.3
Rickenbacher, P.4
Hunziker, P.5
Mueller, C.6
Jeger, R.7
Bader, F.8
Osswald, S.9
Kaiser, C.10
-
11
-
-
33646864489
-
Coronary artery stenting and non-cardiac surgery - A prospective outcome study
-
DOI 10.1093/bja/ael083
-
Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 2006;96:686-93. (Pubitemid 43786682)
-
(2006)
British Journal of Anaesthesia
, vol.96
, Issue.6
, pp. 686-693
-
-
Vicenzi, M.N.1
Meislitzer, T.2
Heitzinger, B.3
Halaj, M.4
Fleisher, L.A.5
Metzler, H.6
-
12
-
-
33846803611
-
Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials
-
DOI 10.1016/j.amjmed.2006.01.023, PII S0002934306001951
-
Bavry AA, Kumbhani DJ, Helton TJ, et al. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-61. (Pubitemid 44826931)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.12
, pp. 1056-1061
-
-
Bavry, A.A.1
Kumbhani, D.J.2
Helton, T.J.3
Borek, P.P.4
Mood, G.R.5
Bhatt, D.L.6
-
13
-
-
33646233783
-
Drug eluting stents: An updated meta-analysis of randomised controlled trials
-
Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 2006;92:641-9.
-
(2006)
Heart
, vol.92
, pp. 641-649
-
-
Roiron, C.1
Sanchez, P.2
Bouzamondo, A.3
-
14
-
-
33744982042
-
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update - Endorsed by the National Heart, Lung, and Blood Institute
-
DOI 10.1161/CIRCULATIONAHA.106.174516, PII 0000301720060516000015
-
Smith Jr SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. (Pubitemid 43947981)
-
(2006)
Circulation
, vol.113
, Issue.19
, pp. 2363-2372
-
-
Smith Jr., S.C.1
Allen, J.2
Blair, S.N.3
Bonow, R.O.4
Brass, L.M.5
Fonarow, G.C.6
Grundy, S.M.7
Hiratzka, L.8
Jones, D.9
Krumholz, H.M.10
Mosca, L.11
Pasternak, R.C.12
Pearson, T.13
Pfeffer, M.A.14
Taubert, K.A.15
-
15
-
-
33745960402
-
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry
-
DOI 10.1161/CIRCULATIONAHA.106.618066, PII 0000301720060620000007
-
Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803-9. (Pubitemid 44305292)
-
(2006)
Circulation
, vol.113
, Issue.24
, pp. 2803-2809
-
-
Spertus, J.A.1
Kettelkamp, R.2
Vance, C.3
Decker, C.4
Jones, P.G.5
Rumsfeld, J.S.6
Messenger, J.C.7
Khanal, S.8
Peterson, E.D.9
Bach, R.G.10
Krumholz, H.M.11
Cohen, D.J.12
-
16
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.2
Hacke, W.3
-
17
-
-
0036570039
-
Patient-reported frequency of taking aspirin in a population with coronary artery disease
-
DOI 10.1016/S0002-9149(02)02272-5, PII S0002914902022725
-
Allen La Pointe NM, Kramer JM, DeLong ER, et al. Patient-reported frequency of taking aspirin in a population with coronary artery disease. Am J Cardiol 2002;89:1042-6. (Pubitemid 34462847)
-
(2002)
American Journal of Cardiology
, vol.89
, Issue.9
, pp. 1042-1046
-
-
Allen LaPointe, N.M.1
Kramer, J.M.2
DeLong, E.R.3
Ostbye, T.4
Hammill, B.G.5
Muhlbaier, L.H.6
McCants, C.B.7
Chen, A.8
Califf, R.M.9
-
18
-
-
28844455699
-
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomised, controlled clinical trial
-
DOI 10.1016/S0140-6736(05)67760-4, PII S0140673605677604
-
Granger BB, Swedberg K, Ekman I, et al. Adherence to can-desartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005;366:2005-11. (Pubitemid 41773375)
-
(2005)
Lancet
, vol.366
, Issue.9502
, pp. 2005-2011
-
-
Granger, B.B.1
Swedberg, K.2
Ekman, I.3
Granger, C.B.4
Olofsson, B.5
McMurray, J.J.6
Yusuf, S.7
Michelson, E.L.8
Pfeffer, M.A.9
-
19
-
-
33749003498
-
Impact of medication therapy discontinuation on mortality after myocardial infarction
-
DOI 10.1001/archinte.166.17.1842
-
Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7. (Pubitemid 44455166)
-
(2006)
Archives of Internal Medicine
, vol.166
, Issue.17
, pp. 1842-1847
-
-
Ho, P.M.1
Spertus, J.A.2
Masoudi, F.A.3
Reid, K.J.4
Peterson, E.D.5
Magid, D.J.6
Krumholz, H.M.7
Rumsfeld, J.S.8
-
20
-
-
0037465436
-
Early and late effects of clopidogrel in patients with acute coronary syndromes
-
DOI 10.1161/01.CIR.0000051362.96946.15
-
Yusuf S, Mehta SR, Zhao F, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003;107:966-72. (Pubitemid 36258718)
-
(2003)
Circulation
, vol.107
, Issue.7
, pp. 966-972
-
-
Yusuf, S.1
Mehta, S.R.2
Zhao, F.3
Gersh, B.J.4
Commerford, P.J.5
Blumenthal, M.6
Budaj, A.7
Wittlinger, T.8
Fox, K.A.A.9
-
21
-
-
38949209538
-
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
-
DOI 10.1001/jama.299.5.532
-
Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008;299:532-9. (Pubitemid 351222546)
-
(2008)
JAMA - Journal of the American Medical Association
, vol.299
, Issue.5
, pp. 532-539
-
-
Ho, P.M.1
Peterson, E.D.2
Wang, L.3
Magid, D.J.4
Fihn, S.D.5
Larsen, G.C.6
Jesse, R.A.7
Rumsfeld, J.S.8
-
22
-
-
33845474736
-
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12 rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
-
DOI 10.1016/j.thromres.2006.01.019, PII S0049384806000491
-
Malinin A, Pokov A, Spergling M, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the verify thrombosis risk assessment (VERITAS) study. Thromb Res 2007;119:277-84. (Pubitemid 44918092)
-
(2007)
Thrombosis Research
, vol.119
, Issue.3
, pp. 277-284
-
-
Malinin, A.1
Pokov, A.2
Spergling, M.3
Defranco, A.4
Schwartz, K.5
Schwartz, D.6
Mahmud, E.7
Atar, D.8
Serebruany, V.9
-
23
-
-
33749520689
-
Premature withdrawal and alternative therapies to dual oral antiplatelet therapy
-
DOI 10.1093/eurheartj/sul055
-
Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J 2006;8(Suppl. G):G46-52. (Pubitemid 44526986)
-
(2006)
European Heart Journal, Supplement
, vol.8
, Issue.SUPPL. G
-
-
Collet, J.-P.1
Montalescot, G.2
-
24
-
-
33845893847
-
Noncardiac Surgery After Coronary Stenting: Early Surgery and Interruption of Antiplatelet Therapy Are Associated With an Increase in Major Adverse Cardiac Events
-
DOI 10.1016/j.jacc.2006.10.004, PII S0735109706024673
-
Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49: 122-4. (Pubitemid 46026891)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.1
, pp. 122-124
-
-
Schouten, O.1
Van Domburg, R.T.2
Bax, J.J.3
De Jaegere, P.J.4
Dunkelgrun, M.5
Feringa, H.H.H.6
Hoeks, S.E.7
Poldermans, D.8
-
25
-
-
33847766568
-
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
-
DOI 10.1056/NEJMoa067484
-
Kastrati A, Mehilli J, Pache J, et al. Analysis of 14trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-9. (Pubitemid 46376803)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.10
, pp. 1030-1039
-
-
Kastrati, A.1
Mehilli, J.2
Pache, J.3
Kaiser, C.4
Valgimigli, M.5
Kelbaek, H.6
Menichelli, M.7
Sabate, M.8
Suttorp, M.J.9
Baumgart, D.10
Seyfarth, M.11
Pfisterer, M.E.12
Schomig, A.13
-
26
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
DOI 10.1056/NEJMoa067731
-
Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. (Pubitemid 46376802)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.10
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.-H.2
Massaro, J.M.3
Ho, K.K.L.4
D'Agostino, R.5
Cutlip, D.E.6
-
27
-
-
33847741037
-
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents
-
DOI 10.1056/NEJMoa066633
-
Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-97. (Pubitemid 46376799)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.10
, pp. 989-997
-
-
Spaulding, C.1
Daemen, J.2
Boersma, E.3
Cutlip, D.E.4
Serruys, P.W.5
-
28
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
-
CAPRIE Steering Committee
-
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
29
-
-
34247869852
-
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
-
DOI 10.1016/j.jacc.2007.03.025, PII S0735109707009928
-
Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007;49: 1982-8. (Pubitemid 46694290)
-
(2007)
Journal of the American College of Cardiology
, vol.49
, Issue.19
, pp. 1982-1988
-
-
Bhatt, D.L.1
Flather, M.D.2
Hacke, W.3
Berger, P.B.4
Black, H.R.5
Boden, W.E.6
Cacoub, P.7
Cohen, E.A.8
Creager, M.A.9
Easton, J.D.10
Hamm, C.W.11
Hankey, G.J.12
Johnston, S.C.13
Mak, K.-H.14
Mas, J.-L.15
Montalescot, G.16
Pearson, T.A.17
Steg, P.G.18
Steinhubl, S.R.19
Weber, M.A.20
Fabry-Ribaudo, L.21
Hu, T.22
Topol, E.J.23
Fox, K.A.A.24
more..
|